Enav SpA (0RIE)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 4.919 |
|---|---|
| 52-week range | 4.179 – 5.435 |
| Return, 1 month / 3 months | −0.9% / −0.9% |
| Return, 1 year / 3 years | +15.9% / +95.3% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 21.8% |
| Worst drawdown (1 year) | -14.2% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 5.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Enav is the Italian company that runs air traffic control and air navigation services across Italy. It guides aircraft through Italian airspace, providing air traffic management for airlines and other aircraft operators, and it maintains the communication, navigation and surveillance systems that support safe flight. Its customers are commercial airlines, cargo carriers and general aviation operators using Italian airports and airspace. The company is based in Rome and is controlled by the Italian state.
The shares are listed on the London Exchange in UK under the code 0RIE, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Enav SpA (0RIE) trades on the London Exchange in UK. It last closed at EUR 4.919 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,372 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.9% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -8.3% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | 1.5% | ||
| 12-month return, skipping the last month | 17.0% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.2% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 20.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.6% |
|---|---|
| 1 month | −0.9% |
| 3 months | −0.9% |
| 6 months | +1.5% |
| 1 year | +15.9% |
| 3 years | +95.3% |
| 5 years | +64.1% |
Signals
| 50-day / 200-day average | 4.934 / 4.920 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.112 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 0.2900 |
| 23 Jun 2025 | EUR 0.2700 |
| 27 May 2024 | EUR 0.2300 |
| 23 Oct 2023 | EUR 0.1967 |
| 24 Oct 2022 | EUR 0.1081 |
| 25 May 2020 | EUR 0.2094 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.